Announced Mon, 21 Sept, 2026 · 18:10 IST
Promoter group Essix Biosciences acquires 70 lakh warrants via preferential issue
Promoter Stake BuyCreeping Acquisition Near ThresholdOwnership Changes View source PDFExplain this filing
INDSWFTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+6.7%1-day move
₹382.00
prior close
₹388.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.8+0.7+1.5+2.4+6.7+4.7+6.8+6.9+8.5+3.1————
Up moveDown movePending
AI summary
Essix Biosciences (part of promoter group) acquired 70,00,000 fully convertible warrants of Ind-Swift Labs on September 17, 2026 via preferential allotment. Promoter group total holding rises from 43.06% to 47.18% on diluted basis. Each warrant convertible into one equity share of Rs 10 face value.
Likely market impact
Promoter group stake rises to 47.18% diluted, nearing 50% threshold. Signals promoter confidence but increases control concentration.